Johansson G, Backman U, Danielson B G, Fellström B, Ljunghall S, Wikström B
J Urol. 1980 Dec;124(6):770-4. doi: 10.1016/s0022-5347(17)55655-4.
Prophylactic treatment with magnesium hydroxide ws instituted in 56 consecutive cases with renal calcium stones. The patients had been investigated previously with regard to the magnesium metabolism. The urinary magnesium excretion increased promptly and remained on a higher level during treatment. No changes were observed in the serum or urinary calcium concentrations. Most patients have undergone treatment for at least 2 years and 45 have been free of recurrences of formations of new stones. The mean stone episode rate during treatment was 0.03 stones per year compared to 0.8 stones per year before treatment was instituted. The natural history of stone disease also was followed in 34 patients with stones who had received no prophylactic therapy and 15 have experienced recurrences after 2 years. Therefore, in comparison, treatment with magnesium hydroxide appeared to reduce the recurrence rate. Apart from minor gastrointestinal discomfort no adverse effects were observed during treatment.
对56例连续性肾钙结石患者采用氢氧化镁进行预防性治疗。这些患者之前已针对镁代谢进行过检查。治疗期间尿镁排泄迅速增加并维持在较高水平。血清或尿钙浓度未观察到变化。大多数患者接受治疗至少2年,45例未出现新结石形成的复发情况。治疗期间平均每年结石发作率为0.03块,而在开始治疗前为每年0.8块。还对34例未接受预防性治疗的结石患者的结石病自然病程进行了跟踪,其中15例在2年后出现复发。因此,相比之下,氢氧化镁治疗似乎降低了复发率。治疗期间除了轻微的胃肠道不适外,未观察到不良反应。